Maria N. Gabe

Copenhagen, 2200, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Global glucagon-like peptide-2 receptor activation linked to increased obesity risk in the UK Biobank.

Global glucagon-like peptide-2 receptor activation linked to increased obesity risk in the UK Biobank.

Journal: Metabolism: clinical and experimental

Published: August 09, 2025

Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.

Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.

Journal: Diabetes, obesity & metabolism

Published: July 30, 2024

Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: A randomized controlled trial.

Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: A randomized controlled trial.

Journal: Diabetes, obesity & metabolism

Published: April 19, 2024

Biased GLP-2 agonist with strong G protein-coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice.

Biased GLP-2 agonist with strong G protein-coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice.

Journal: British journal of pharmacology

Published: July 27, 2022

N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of GLP-2 receptor selectivity towards more GLP-1 receptor interaction.

N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of GLP-2 receptor selectivity towards more GLP-1 receptor interaction.

Journal: British journal of pharmacology

Published: August 30, 2021

GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment.

GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment.

Journal: Pharmacological research

Published: August 30, 2021

Glucose-dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet-fed mice.

Glucose-dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet-fed mice.

Journal: British journal of pharmacology

Published: May 25, 2021

Novel agonist and antagonist radioligands for the GLP-2 receptor. Useful tools for studies of basic GLP-2 receptor pharmacology.

Novel agonist and antagonist radioligands for the GLP-2 receptor. Useful tools for studies of basic GLP-2 receptor pharmacology.

Journal: British journal of pharmacology

Published: August 18, 2020

Molecular interactions of full-length and truncated GIP peptides with the GIP receptor - A comprehensive review.

Molecular interactions of full-length and truncated GIP peptides with the GIP receptor - A comprehensive review.

Journal: Peptides

Published: October 07, 2019

Paracrine crosstalk between intestinal L- and D-cells controls secretion of glucagon-like peptide-1 in mice.

Paracrine crosstalk between intestinal L- and D-cells controls secretion of glucagon-like peptide-1 in mice.

Journal: American journal of physiology. Endocrinology and metabolism

Published: September 11, 2019

Enhanced agonist residence time, internalization rate and signalling of the GIP receptor variant [E354Q] facilitate receptor desensitization and long-term impairment of the GIP system.

Enhanced agonist residence time, internalization rate and signalling of the GIP receptor variant [E354Q] facilitate receptor desensitization and long-term impairment of the GIP system.

Journal: Basic & clinical pharmacology & toxicology

Published: May 20, 2019

GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men.

GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men.

Journal: Bone

Published: January 22, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026